nivolumab,brentuximab vedotin
bms,seagen
[' vedo', 'hodgkin', 'brentuximab', 'nivo', 'lymsm', 'imab ']
second line data in hodgkin. impressive activity of nice (orr 100). agree it does look good #ash22 #lymsm 
BMT & Cellular Therapy | #Lymphoma | Co-Chair @ASTCT CoPG | #bmtsm #CARTcell #lymsm | Personal views | Physician ? Provider | ???? ?? ???? ??